- Category
- Medium (2024-25)
- Udyam number
- UDYAM-MH-19-0150199

About Laboratoires Griffon Private Limited
Data last updated:
Laboratoires Griffon Private Limited is a private limited company based in Kolkata, West Bengal, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 31 May 1947 and has been in existence for over 79 years.
Its director Postel Pascal and family are #893 among India's richest people (2026).
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24239WB1947PTC015405. Its GSTIN is 07AAACL4591N1Z2 (Delhi). The company holds 16 GST registrations, of which 13 are active.
The company has an authorised share capital of ₹95 Lakh and a paid-up capital of ₹32.06 Lakh. It was formerly known as Laboratoires Griffon Limited. It is led by directors including Errol James Desouza and Jagdish Purushottamdas Mehta.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 40B Princep Street, Kolkata, West Bengal, India – 700072.
As per the financials filed for FY 2024, the company reported a revenue of ₹161.12 Cr, a growth of 8% compared to the previous year. For the same year it recorded a net profit of ₹9.04 Cr (net margin 5.6%) and EBITDA of ₹15.16 Cr (EBITDA margin 9.4%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 6% over five years.
The company has about 86 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹1 Lakh on record. Court records list 54 cases involving the company, including 50 filed by the company and 4 filed against it; 26 cases are pending. The company has 4 deals on record (4 secondary share transfers); the latest was in August 2011. Its 4 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 smaller; the largest is Elysium Pharmaceuticals Ltd with revenue of ₹159.55 Cr. The company has 3 MSME Form 1 returns on record between 2019 and 2020, listing 23 overdue payments to 15 micro and small suppliers.
Laboratoires Griffon Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0150199). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website francoindian.com.
Company details
Recognitions & Rankings of Laboratoires Griffon
- #893 Postel Pascal & family ₹3,300 Cr
Contact details
Laboratoires Griffon Private Limited's registered office is in Kolkata, West Bengal. Its website is francoindian.com. Its e-mail address is in the company report.
- Email
- Website
- Registered Address40B Princep Street, Kolkata, West Bengal, India – 700072
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Laboratoires Griffon Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Laboratoires Griffon is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Laboratoires Griffon Private Limited, buy the company report.
Financials of Laboratoires Griffon Private Limited
FY 2025 filings availableLaboratoires Griffon Private Limited reported revenue of ₹161.12 Cr (up 8% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 6% over five years, including 8% growth in the latest year. EBITDA rose 21% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹15.16 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹9.04 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.4% | ||||
| Net Profit Margin | 5.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Laboratoires Griffon Private Limited, buy the company report.
Board of directors of Laboratoires Griffon Private Limited
Laboratoires Griffon has 8 current directors and 11 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Errol James Desouza Also directs: Princeps Pharmaceuticals Private Limited, Franco Indian Medicare Pvt Ltd, Franco Indian Therapeutics Pvt. Ltd. and 5 more | Director | 14 Jan 2025 | 1 Years 10 Months | Current |
| Jagdish Purushottamdas Mehta | Director | 17 Dec 2003 | 22 Years 11 Months | Current |
| Santoshkumar Gupta Also directs: Franco-Indian Remedies Private Limited | Director | 11 Dec 2001 | 24 Years 11 Months | Current |
| Nelson Mathew Lopes | Director | 30 Jan 2018 | 8 Years 9 Months | Current |
| Vijay Laxman Badgujar Also directs: Franco-Indian Remedies Private Limited | Director | 28 Apr 2023 | 3 Years 6 Months | Current |
| Rajesh Tribhuvan Singh Also directs: Franco Indian Therapeutics Pvt. Ltd. | Director | 23 Feb 2021 | 5 Years 8 Months | Current |
Peer comparison
Laboratoires Griffon Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Laboratoires Griffon Private Limitedthis company | ₹161.12 Cr (FY 2024) | ₹9.04 Cr | 5.6% | 8.0% | Kolkata, West Bengal, India | |
| Elysium Pharmaceuticals Ltd | ₹159.55 Cr (FY 2024) | -26.0% | Vadodara, Gujarat, India | |||
| VHB Medi Sciences Limited | ₹159.28 Cr (FY 2025) | 14.0% | Kandivlai West, Maharashtra, India | |||
| Jenburkt Pharmaceuticals Ltd | ₹158.41 Cr (FY 2025) | 8.0% | Mumbai, Maharashtra, India | |||
| Wardex Pharmaceuticals Private Limited | ₹158.1 Cr (FY 2025) | 8.0% | Chennai, Tamil Nadu, India |
To see the full peer comparison of Laboratoires Griffon Private Limited, buy the company report.
Auditor
Laboratoires Griffon Private Limited is audited by M/s. N. Sarkar & Co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M/s. N. Sarkar & Co. | FY 2023 | 301075E |
Shareholding
The shareholding of Laboratoires Griffon Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Laboratoires Griffon Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 May 2019 | 100268130 | Others | ₹1 Lakh | Open |
Total charge records: 1 View all charges
Deals & funding
Laboratoires Griffon Private Limited has 4 deals on record (4 secondary share transfers); the latest was in August 2011.
Deals on record (4 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Aug 2011 | Secondary share transfer | Undisclosed | Buyer: Franco-Indian Holdings Private Limited Seller: Medibest Investments Private Limited |
| Jun 2008 | Secondary share transfer | Undisclosed | Buyer: Ward Pharmaceuticals Limited, an individual Seller: Waregoods Limited, Franco Indian Research Private Limited , Franco Indian Medicare Pvt Ltd |
| Nov 2007 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Jun 2007 | Secondary share transfer | Undisclosed | Buyer: Waregoods Limited Seller: Dolphin Pharmaceutical |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Laboratoires Griffon Private Limited has 54 court cases on record: 50 filed by Laboratoires Griffon, 4 filed against it. 26 cases are pending and 28 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 49 | 2 | 24 |
| District courts | 5 | 2 | 2 |
Cases on record (5 of 54)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (LPETN) | Filed by the company against Addii Biotech Private Limited and 2 others | Pending |
| Bombay High Court | Court case (COMIP) | Filed by the company against Addii Biotech Private Limited and 2 others | Pending |
| High Court | Court case (COMIP) | Filed by the company against Magnomed Pharmaceuticals LLP and 5 others | Pending |
| High Court | Court case (COMIP) | Filed by the company against Unispeed Pharmaceuticals Private Limited and 2 others | Pending |
| High Court, MAHARASHTRA | Court case (COMIP) | Filed by the company against Medieos Lifesciences LLP and 1 other | Pending |
To see the full case history of Laboratoires Griffon Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Laboratoires Griffon Private Limited has 3 MSME Form 1 returns on record between 2019 and 2020, listing 23 overdue payments to 15 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 15)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Mike Offset | |||
| an individual supplier | |||
| an individual supplier | |||
| Bombay Carbon and Metcaps Private Limited | |||
| Ven Petrochem & Pharma (India) Private Limited |
To see the full MSME payment records of Laboratoires Griffon Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
Laboratoires Griffon has 16 GST registrations: 13 active and 3 cancelled or inactive. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAACL4591N1Z2 | Delhi | Active | 01 Jul 2017 |
| 08AAACL4591N1Z0 | Rajasthan | Active | 01 Jul 2017 |
| 09AAACL4591N1ZY | Uttar Pradesh | Active | 01 Jul 2017 |
| 10AAACL4591N1ZF | Bihar | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Laboratoires Griffon Private Limited, buy the company report.
Recent activity
Laboratoires Griffon Private Limited has 19 board changes on record since 2001: 8 appointments and 11 cessations. The latest: Errol James Desouza was appointed as Director on 14 Jan 2025.
11 earlier events are in the company report.
Frequently asked questions
Laboratoires Griffon is an active private limited company based in Kolkata, West Bengal, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 31 May 1947 (79+ years old) and is registered under CIN U24239WB1947PTC015405.
Laboratoires Griffon has 8 current directors:
- Errol James Desouza - Director
- Jagdish Purushottamdas Mehta - Director
- Santoshkumar Gupta - Director
- Nelson Mathew Lopes - Director
- Vijay Laxman Badgujar - Director
- Rajesh Tribhuvan Singh - Director
- Lalsa Balgovind Yadav - Director
- Pascal Postel - Director
The latest financial statements of Laboratoires Griffon on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Laboratoires Griffon is 07AAACL4591N1Z2, registered in Delhi. The company has 16 GST registrations in all, of which 13 are active and 3 are cancelled or inactive. Other active GSTINs include 08AAACL4591N1Z0 (Rajasthan), 09AAACL4591N1ZY (Uttar Pradesh), 10AAACL4591N1ZF (Bihar).
The CIN (Corporate Identification Number) of Laboratoires Griffon is U24239WB1947PTC015405. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Laboratoires Griffon has 54 court cases on record: 50 filed by the company and 4 filed against it. 26 are pending. Most are in the high courts.
Laboratoires Griffon was incorporated on 31 May 1947, making it 79+ years old. It is registered with the Registrar of Companies, Kolkata.
Laboratoires Griffon has 4 deals on record (4 secondary share transfers); the latest was in August 2011.
The peers of Laboratoires Griffon by revenue are Elysium Pharmaceuticals Ltd, VHB Medi Sciences Limited, Jenburkt Pharmaceuticals Ltd, Wardex Pharmaceuticals Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Errol James Desouza was appointed as Director on 14 Jan 2025. Vijay Laxman Badgujar ceased to be Additional Director on 28 Sep 2023. Vijay Laxman Badgujar was appointed as Director on 28 Apr 2023. Laboratoires Griffon has 19 board changes on record in total.
Yes, Laboratoires Griffon is registered as a medium enterprise under Udyam registration (number: UDYAM-MH-19-0150199).
Laboratoires Griffon has 3 MSME Form 1 returns on record between 2019 and 2020, listing 23 overdue payments to 15 micro and small suppliers. The latest return was filed on 12 Aug 2020.

